June 4, 2017 In a study of 447 patients with biliary tract cancers, capecitabine improved overall survival (OS) when used after surgery and “should become the standard of care,” John N. Primrose, MD, of the University of Southampton, United Kingdom, said during the Gastrointestinal (Noncolorectal) Cancer Oral Abstract Session on June 4. The BILCAP...
Pro zobrazení tohoto obsahu je třeba být přihlášen.